SCHEMBL4143162

SCHEMBL4143162

Cn1nc(C(C)(C)C)c2nc(N(CCN3CCOCC3)Cc3ccc(F)cc3)[nH]c(=O)c21

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 3/20 0.42
KDM4E B2RXH2 7/20 0.40
ALOX15 P16050 2/20 0.38
LMNA P02545 2/20 0.38
TSHR P16473 2/20 0.38
TP53 P04637 1/20 0.38
PDE9A O76083 1/20 0.37
PDE1A P54750 1/20 0.37
PDE1B Q01064 1/20 0.37
PDE1C Q14123 1/20 0.37
ALDH1A1 P00352 8/20 0.37
POLB P06746 2/20 0.37
USP2 O75604 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
SMN1; SMN2 Q16637 4/20 0.36
HPGD P15428 3/20 0.36
HSD17B10 Q99714 3/20 0.36
MAPK1 P28482 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4131950 0.95 GAA (0.41) GAAKDM4EALOX15LMNATSHR
SCHEMBL3996853 0.83 GAA (0.42) GAAKDM4EALOX15LMNATSHR
SCHEMBL8048797 0.82 PDE9A (0.38) GAAKDM4ELMNAPDE9APDE1A
SCHEMBL8034133 0.81 KDM4E (0.36) KDM4ELMNAPDE9APDE1APDE1B
SCHEMBL4893657 0.81 KDM4E (0.43) GAAKDM4ELMNATSHRTP53
SCHEMBL4125332 0.81 PDE5A (0.46) GAAKDM4EALOX15LMNATSHR
SCHEMBL4132815 0.80 KDM4E (0.41) KDM4ELMNATP53ALDH1A1POLB
SCHEMBL4117755 0.79 KDM4E (0.41) KDM4ELMNATSHRPDE9AALDH1A1
SCHEMBL8043859 0.79 KDM4E (0.36) KDM4ELMNAPDE9APDE1APDE1B
SCHEMBL4136563 0.78 PDE5A (0.43) GAAKDM4EPDE9APDE1APDE1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009071706-A1 PYRAZOLEPYRIMIDINE COMPOUNDS USEFUL FOR THE TREATMENT OF DEGENERATIVE & INFLAMMATORY DISEASES GALAPAGOS NV (BE) 2009-06-11 WO disclosed